Abstract The nodular lymphoid lesion of the liver known as reactive lymphoid hyperplasia or pseudolymphoma is rare and its pathogenesis is unknown. We report two cases of nodular lymphoid lesions of the liver with numerous IgG4-positive plasma cells in patients with primary biliary cirrhosis. Histologically, in both cases, the lesion showed a dense lymphoplasmacytic infiltrate with lymphoid follicles and granulomas. Fibrous tissue was scarce and without a storiform pattern. Obliterative phlebitis was not identified. The IgG4+ plasma cell counts were 82 and 76 per high power field, with an IgG4/IgG ratio of 75 and 64 %, respectively, which qualifies the lesions according to the diagnostic criteria for IgG4-related disease as « probable histological feature of IgG4-related disease ». There were no rearrangements of immunoglobulin heavy-chain genes and plasma cells had a polytypic pattern of kappa and lambda light-chain expression. The nontumor liver showed primary biliary cirrhosis with destructive cholangitis without IgG4 plasma cells. In both cases, IgG4-related disease was not found in other organs neither at the time of diagnosis nor 3 years later. Serum IgG4 levels normalized after local ablation of the lesions. It seems unlikely that these lesions are a manifestation of IgG4-related disease. However, because the pathogenesis of both nodular lymphoid lesions and IgG4-related disease remains unclear, further studies are needed to elucidate a potential link between nodular lymphoid lesions of the liver and an increased number of IgG4 plasma cells. More definite conclusions will be possible when the pathogenesis of IgG4-related disease has been clarified.
Introduction
Nodular lymphoid lesion of the liver, also called nodular reactive lymphoid hyperplasia or pseudolymphoma, is a rare condition that appears as liver nodules. Typically, it affects adult women and can be associated with autoimmune disease, chronic hepatitis, or a past history of malignancy. The pathogenesis of this lesion is so far unknown and has been suggested to be autoimmune [1] [2] [3] . Histologically, it consists of lymphoid tissue with lymphoid follicles, a dense lymphoplasmacytic infiltrate, and clusters of epithelioid cells. The main differential diagnosis is low-grade B cell lymphoma, particularly marginal zone B cell lymphoma [4] . Recently, some reactive lymphoid infiltrates with an increased number of IgG4-positive (+) plasma cells have been associated with IgG4-related disease [5, 6] .
We report two cases of reactive lymphoid hyperplasia of the liver with an increased number of IgG4+ plasma cells in patients with primary biliary cirrhosis (PBC). We discuss the relationship of these lesions with IgG4-related disease.
Clinical history Case 1
A 70-year-old woman with a history of PBC presented with abdominal pain. An abdominal ultrasound revealed a 23-mm left lobe liver nodule. PBC had been diagnosed 6 years earlier by the presence of cholestasis with type M2 antimitochondrial antibodies (>1/640). Rheumatoid factor antibodies, Sjögren syndrome-A antibodies, Sjögren syndrome-B antibodies, and antinuclear antibodies were negative. Hepatitis B and C serology was negative. A liver biopsy performed at that time showed a Ludwig stage 2 PBC. The patient was treated with ursodeoxycholic acid (15 mg/kg/day) leading to normalization of the liver function tests (bilirubin, alkaline phosphatase, γ-glutamyltransferase, aspartate aminotransferase, alanine aminotransferase).
On MRI, the lesion measured 23 mm and was enhanced at the arterial phase with no washout at the portal phase (Fig. 1a,  b) . The liver was not dysmorphic and there was no sign of portal hypertension. On the PET scan, the lesion appeared hypermetabolic without any other hypermetabolic foci. Alpha-fetoprotein and carcinoembryonic antigen serum levels were within normal range. Resection of the left lobe of the liver was performed.
Two years after the surgical resection, the patient had a lobular breast carcinoma treated by surgery, radiotherapy, and letrozole. No other particular event occurred within the 3-year follow-up.
IgG4-related disease was not found in other organs and IgG4 serum levels measured after surgery were normal (<140 mg/dL).
Case 2
An 80-year-old woman with a history of PBC diagnosed 2 years before underwent a routine liver ultrasound, which revealed a 13-mm hypoechogenic right liver nodule. PBC was diagnosed by the presence of cholestasis with type M2 antimitochondrial antibodies (1/640). A liver biopsy was performed and showed a Ludwig's stage 2 PBC. The patient was treated with ursodeoxycholic acid (15 mg/kg/day), leading to normalization of liver function tests.
The patient was also diagnosed with Sjögren syndrome with xerostomia and positive Sjögren syndrome antibodies. CT scan and MRI showed an arterial phase enhancement of the liver lesion with a portal phase washout, suggesting hepatocellular carcinoma (Fig. 2a, b) . A biopsy of the lesion followed by radiofrequency ablation was performed. A concomitant biopsy in the non-tumoral liver was also performed. Three years after radiofrequency ablation, there was no recurrence.
IgG4-related disease was not found in other organs, and IgG4 serum levels, measured after radiofrequency ablation, were normal (<140 mg/dL).
Materials and methods
Formalin-fixed, paraffin-embedded (FFPE) tissues were cut into 3-μm-thick sections and were submitted for H&E, Ziehl-Neelsen, Gomori-Grocott, and orcein stainings; immunohistochemistry (IHC); and in situ hybridization.
IHC was performed using a Bond-Max automated immunostainer (Leica Microsystems) using the following antibodies with prior antigen retrieval (10 mM citrate buffer, pH 6): CD3 (Neomarker, 1:300), CD5 (Novocastra, 1:50), CD20 (Novocastra, 1:350), CD21 (Novocastra, 1:100), CD23 (Novocastra, 1:50), CD43 (Dako, 1:75), CD138 (Dako, 1:100), IgG4 (Binding Site, 1:200), IgG (Dako, 1:1000), kappa (DB-Biotech, 1:500), and lambda (DB-Biotech, 1:2000) light chains. In order to exclude Epstein-Barr virus (EBV)-induced proliferation, EBV detection was performed by in situ hybridization using an EBV-encoded RNA probe (EBER) (Leica, ISH EBER ready-to-use oligonucleotide probe). IgG4+ plasma cells were counted on the three HPFs (×400, 0.24 mm 2 per field) with the highest number of IgG4+ plasma cells, and an average was determined. IgG plasma cells were counted in the same way on the same three fields to provide the IgG4/IgG ratio [7] . DNA was extracted from the FFPE tissue (QIAsymphony DSP DNA Mini Kit, Qiagen). Clonal immunoglobulin heavychain rearrangement was searched in case no. 1 using three VH-JH fluorescent multiplex PCR followed by fragment length analysis, according to the BIOMED-2 standardization protocol [8] .
Results

Case 1
Grossly, the lesion measured 18 mm, appeared white, homogeneous, and well circumscribed (Fig. 1c) . Histologically, it consisted of lymphoid follicles with a dense lymphoplasmacytic infiltrate containing abundant regular plasma cells and clusters of epithelioid histiocytes, forming granulomas (Fig. 1d) . Fibrous tissue was scarce within the lesion, with no storiform pattern. Obliterative phlebitis was not identified.
No infectious pathogen was identified on Ziehl-Neelsen and Gomori-Grocott stainings. IHC profile showed a majority of CD138+ cells, with CD20+ and CD3+ small lymphocytes. There was no abnormal expression of CD5 or CD23. The kappa/lambda ratio of plasma cells was normal with a polyclonal pattern. EBV-encoded small RNAs were not detected. The IgG4+ plasma cell count was 82 per HPF (Fig. 1e) and the IgG4/IgG ratio was 75 % (IgG plasma cells 109/HPF). There was no rearrangement of immunoglobulin heavy chains using FR1/JH, FR2/JH, and FR3/JH primers in the lymphoid tissue. In non-tumoral liver, there were a few fibrous septa, mild steatosis, a lymphoplasmacytic portal inflammatory infiltrate with lymphocytic destructive cholangitis (Fig. 1f) , and mild interface hepatitis suggestive of stage 3 PBC. There were no IgG4+ plasma cells in the non-tumoral liver (Fig. 1g) .
Case 2
Histological examination of the biopsy specimen showed the same pattern as in case 1, with abundant non-atypical plasma cells and small lymphocytes. There were some epithelioid histiocytes and a slight non-storiform fibrosis (Fig. 2c) . The kappa/ lambda ratio of plasma cells was normal with a polyclonal pattern. The IgG4+ plasma cells count was 76 per high power field and the IgG4/IgG ratio was 64 % (IgG plasma cells 118/HPF). The non-tumoral liver biopsy showed a Ludwig stage 2 PBC with a dense portal lymphoplasmacytic infiltrate, lymphocytic, and granulomatous cholangitis (Fig. 2e) ; moderate interface hepatitis; and periportal fibrosis without bridging. There were no IgG4+ plasma cells in the non-tumoral liver (Fig. 2f) .
Discussion
These two cases of nodular lymphoid lesions of the liver showed a typical histological aspect with a dense lymphoplasmacytic infiltrate, lymphoid follicles, and epithelioid granulomas without rearrangement of immunoglobulin heavy chains using FR1/JH and FR2/JH [1] [2] [3] . However, there were abundant IgG4+ plasma cells within these lesions which, to our knowledge, have not been previously described in nodular lymphoid lesions of the liver.
Our observations led us to consider whether or not these lesions might be a manifestation of IgG4-related disease. Importantly, an increasing number of lesions rich in IgG4+ plasma cells have been identified since the concept of IgG4-related disease has emerged. However, these lesions do not always belong to the spectrum of IgG4-related disease. For instance, abundant IgG4+ plasma cell infiltrates have been identified in primary sclerosing cholangitis, inflammatory bowel disease, rheumatoid arthritis, and carcinoma [9] [10] [11] [12] .
The diagnosis of IgG4-related disease is based on a combination of clinical and histopathological features. Typical histological features combine a dense lymphoplasmacytic infiltrate with abundant IgG4+ plasma cells, storiform fibrosis, and obliterative phlebitis [7, 13] . Even some lesions with atypical histological aspects are suggested to belong to the spectrum of IgG4-related disease [14, 15] .
In our two cases, despite a dense lymphoplasmacytic infiltrate with an increased number of IgG4+ plasma cells (>50/HPF on gross specimen, and >10/HPF on biopsy with a, IgG4/IgG ratio >40 %), some characteristic features of IgG4-related disease were missing, i.e., a lack of significant fibrosis and obliterative phlebitis. According to the Deshpande et al. diagnostic criteria for IgG4-related disease, our cases belong to the « probable histological feature of IgG4-related disease » category [7] . The diagnosis of IgG4-related disease requires additional clinical, radiological, and/or serological evidence, which were all missing in our cases. The serum levels of IgG4 were normal at the time of local ablation of the focal lesion and the patients had no other organ manifestation of IgG4-related disease, in particular no pancreatic, biliary, salivary, cutaneous, or pulmonary lesion, either at baseline or 3 years after local treatment. The response to corticosteroid therapy can also be a strong argument to underpin a diagnosis of IgG4-related disease, but it could not be assessed in our cases since the lesions were ablated.
The histological features in our cases also included the presence of prominent granulomas. Granulomas are usually regarded as a feature that is not seen in IgG4-related disease. In most settings, their presence would make this diagnosis very unlikely, even though Bateman et al. recently highlighted the fact that granulomas may be seen in lymph nodes in IgG4-related disease [15] .
The pathological aspects of the non-tumoral liver in our cases did not provide any evidence for liver IgG4 hepatopathy. According to Umemura et al., histological findings in the liver of patients with IgG4-related pancreatitis can have several patterns: (1) a portal inflammation pattern, with intense portal inflammation with or without interface hepatitis; (2) a large duct damage pattern, characterized by bile ductular proliferation, neutrophilic infiltration, and edematous change in the portal areas; (3) a portal sclerosis pattern, exhibiting dense portal sclerosis with scarce portal inflammation; (4) a lobular hepatitis pattern, showing lobular inflammation with hepatocellular necrosis resembling viral hepatitis; or (5) a cholestatic pattern, with canalicular cholestasis predominantly in the centrilobular area [16] . Perivenular accentuation of the portal infiltrate and portal-based fibroinflammatory nodules have also been described in the liver of patients with IgG4-related cholangitis [17] . The only common feature in all these patterns is a prominent IgG4+ plasma cell infiltrate.
In our cases, the pathological aspects of the non-tumoral liver might be consistent with the portal inflammation pattern, but its lack of IgG4+ plasma cells, combined with granulomatous cholangitis and typical serum immunological abnormalities (antimitochondrial M2 antibodies >1/640), precludes the diagnosis of liver IgG4-related disease and was typical of PBC [16, 17] . All these arguments suggest that the lesions in our cases may not be a manifestation of IgG4-related disease. However, conversely, it has been suggested that pulmonary pseudolymphoma might be a form of IgG4-related sclerosing disease with no other typical feature than a rich IgG4+ plasma cell infiltrate and a high IgG4/IgG ratio [6] . The histological findings of this lung lesion have many similarities with our cases, namely, lymphoid follicles with a variable degree of fibrosis, sheets of interfollicular plasma cells, and the absence of obliterative phlebitis.
A peculiar finding in our cases was that they occurred in patients with PBC. Whereas reactive nodular lymphoid hyperplasia has been described in association with PBC, IgG4+ plasma cell infiltrates have not been identified in PBC livers [18] . The Th1 and Th17 signaling pathways have been associated with the pathogenesis of PBC [19] . In contrast, the immunological profile of IgG4-related disease is a Th2-celldominant immune response in affected sites and in peripheral blood T cell lymphocytes [20, 21] . However, the pathogenesis of an IgG4+ plasma cell-rich lesion in an organ affected by a Th1-related autoimmune disease, namely PBC, is unclear.
To conclude, we describe two cases of nodular lymphoid lesions of the liver with abundant IgG4+ plasma cells occurring in patients with PBC. It seems unlikely that these lesions are a manifestation of IgG4-related disease. However, because the pathogenesis of both nodular lymphoid lesions and IgG4-related disease remain unclear, studying IgG4+ plasma cell infiltrates in a larger number of nodular lymphoid lesions and determining the precise pathogenesis of IgG4-related disease are necessary.
